PharmaCyte Biotech (PMCB) Short Interest Ratio & Short Volume → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free PMCB Stock Alerts $2.10 +0.01 (+0.48%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial Media PharmaCyte Biotech Short Interest DataCurrent Short Volume13,000 sharesPrevious Short Volume18,200 sharesChange Vs. Previous Month-28.57%Dollar Volume Sold Short$27,560.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares8,450,000 sharesFloat Size7,610,000 sharesShort Percent of Float0.17%Today's Trading Volume3,176 sharesAverage Trading Volume7,322 sharesToday's Volume Vs. Average43% Short Selling PharmaCyte Biotech ? Sign up to receive the latest short interest report for PharmaCyte Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPMCB Short Interest Over TimePMCB Days to Cover Over TimePMCB Percentage of Float Shorted Over Time Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… PharmaCyte Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202413,000 shares $27,560.00 -28.6%0.2%0.5 $2.12 4/15/202418,200 shares $38,402.00 -60.2%0.2%0.7 $2.11 3/31/202445,700 shares $108,309.00 +501.3%0.6%1.8 $2.37 3/15/20247,600 shares $14,820.00 -68.7%0.1%0.3 $1.95 2/29/202424,300 shares $51,030.00 -4.3%0.3%1.6 $2.10 2/15/202425,400 shares $53,086.00 -19.4%0.4%1.6 $2.09 Get the Latest News and Ratings for PMCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/31/202431,500 shares $68,985.00 +18.9%0.4%2 $2.19 1/15/202426,500 shares $59,625.00 -14.8%0.4%1.5 $2.25 12/31/202331,100 shares $67,176.00 +15.2%0.5%1.8 $2.16 12/15/202327,000 shares $58,050.00 +2.7%0.4%1.5 $2.15 11/30/202326,300 shares $59,438.00 -9.6%0.4%1.4 $2.26 11/15/202329,100 shares $59,364.00 -12.6%0.4%1.5 $2.04 10/31/202333,300 shares $70,596.00 -17.4%0.5%1.6 $2.12 10/15/202340,300 shares $84,227.00 -12.2%0.6%1.9 $2.09 9/30/202345,900 shares $96,390.00 -27.8%0.7%2.1 $2.10 9/15/202363,600 shares $159,000.00 +27.0%0.9%3 $2.50 8/31/202350,100 shares $122,745.00 -4.0%0.6%1.9 $2.45 6/30/202139,300 shares $424.44 +48.9%N/A0 $0.01 6/15/202126,400 shares $298.32 -27.7%N/A0 $0.01 5/28/202136,500 shares $463.55 -69.0%N/A0 $0.01 5/14/2021117,600 shares $1,481.76 +113.4%N/A0 $0.01 4/30/202155,100 shares $936.70 -72.2%N/A0 $0.02 4/15/2021198,000 shares $3,245.22 +11.1%N/A0 $0.02 3/31/2021178,200 shares $3,073.95 +11.0%N/A0 $0.02 3/15/2021160,500 shares $3,370.50 +817.1%N/A0 $0.02 2/26/202117,500 shares $507.50 -93.3%N/A0 $0.03 2/12/2021260,800 shares $4,824.80 +327.5%N/A0 $0.02 1/29/202161,000 shares $1,037.00 +42.9%N/A0 $0.02 1/15/202128,200 shares $383.52 -69.7%N/A0 $0.01 12/31/202041,700 shares $271.05 +47.9%N/A0 $0.01 12/15/202028,200 shares $155.10 -69.7%N/A0 $0.01 11/30/202093,200 shares $559.20 +486.2%N/A0 $0.01 11/15/202015,900 shares $108.12 No ChangeN/A0 $0.01 10/30/202015,900 shares $141.51 +13.6%N/A0 $0.01 10/15/202014,000 shares $131.60 -74.0%N/A0 $0.01 9/30/202053,900 shares $916.30 +20.0%N/A0 $0.02 9/15/202044,900 shares $493.90 -58.9%N/A0 $0.01 8/31/2020109,300 shares $1,300.67 +680.7%N/A0 $0.01 8/14/202014,000 shares $196.00 -95.6%N/A0 $0.01 7/31/2020319,600 shares $4,474.40 +413.0%N/A0 $0.01Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… PMCB Short Interest - Frequently Asked Questions What is PharmaCyte Biotech's current short interest? Short interest is the volume of PharmaCyte Biotech shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 13,000 shares of PMCB short. 0.17% of PharmaCyte Biotech's shares are currently sold short. Learn More on PharmaCyte Biotech's current short interest. What is a good short interest percentage for PharmaCyte Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.17% of PharmaCyte Biotech's floating shares are currently sold short. Is PharmaCyte Biotech's short interest increasing or decreasing? PharmaCyte Biotech saw a decline in short interest in April. As of April 30th, there was short interest totaling 13,000 shares, a decline of 28.6% from the previous total of 18,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PharmaCyte Biotech's float size? PharmaCyte Biotech currently has issued a total of 8,450,000 shares. Some of PharmaCyte Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PharmaCyte Biotech currently has a public float of 7,610,000 shares. How does PharmaCyte Biotech's short interest compare to its competitors? 0.17% of PharmaCyte Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to PharmaCyte Biotech: Senti Biosciences, Inc. (1.05%), Aptose Biosciences Inc. (0.86%), Evaxion Biotech A/S (0.98%), ZIVO Bioscience, Inc. (4.24%), Coeptis Therapeutics Holdings, Inc. (0.57%), Genetic Technologies Limited (0.58%), BioCardia, Inc. (0.96%), Organovo Holdings, Inc. (4.09%), Creative Medical Technology Holdings, Inc. (1.55%), Titan Pharmaceuticals, Inc. (1.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short PharmaCyte Biotech stock? Short selling PMCB is an investing strategy that aims to generate trading profit from PharmaCyte Biotech as its price is falling. PMCB shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PharmaCyte Biotech? A short squeeze for PharmaCyte Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PMCB, which in turn drives the price of the stock up even further. How often is PharmaCyte Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMCB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Senti Biosciences Short Squeeze Aptose Biosciences Short Squeeze Evaxion Biotech A/S Short Squeeze ZIVO Bioscience Short Squeeze Coeptis Therapeutics Short Squeeze Genetic Technologies Short Squeeze BioCardia Short Squeeze Organovo Short Squeeze Creative Medical Technology Short Squeeze Titan Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PMCB) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits